Inhibition of Regeneration Restraining Pathways to Promote Healing
抑制再生抑制途径以促进愈合
基本信息
- 批准号:10928440
- 负责人:
- 金额:$ 36.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-18 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAntibodiesAutoimmune DiseasesBacterial InfectionsBiologicalBiological AssayBiological Response Modifier TherapyBlood CellsBlood VesselsCASP1 geneCTLA4 geneCaspaseCaspase InhibitorCellsClinicDataDouble-Stranded RNAElementsEmbryonic DevelopmentEpitheliumExcisionFasciaFc ReceptorFutureGenesGeneticGoalsGrantHairHair follicle structureHealthHumanImmuneImmune systemInfectionInfiltrationInjuryIntestinesKnockout MiceLGR5 geneMediatingMonoclonal AntibodiesMusNatural regenerationNeomycin resistance geneNervePD-1/PD-L1Pathway interactionsPatientsPublishingRegenerative capacityReportingResearchSkinSmall Interfering RNATLR2 geneTLR3 geneTestingTherapeuticTissuesUntranslated RNAantagonistanti-PD-L1 antibodiesautoinflammatory diseasescancer therapycell typecheckpoint therapyclinical careepithelium regenerationgain of functionhealingimprovedinhibitor therapyinjury recoveryinsightkeratinocyteloss of functionneutralizing antibodynovelnovel therapeuticsnull mutationorgan injurypharmacologicpreventprogramsreceptorregenerativeregenerative therapyrepairedresponseresponse to injuryrestraintside effectsingle-cell RNA sequencingskin woundstem cellstherapy developmentwound
项目摘要
Project Summary Abstract
The long term objective of the proposed research is to enhance healing after injury that is often slow and
incomplete. We hypothesized that injury to epithelial tissue like skin and gut share commonalities in healing,
with some native injury responses which actually restrain healing. The goal of this grant is to define the
mechanism of this restraint in hopes of developing therapies to enhance healing. We will test if inhibition of
these pathways that restrain healing can improve regeneration after injury or infection to the gut or skin in the
hopes of suggesting a new class of therapeutics to aid healing from diverse injuries.
项目摘要摘要
拟议研究的长期目标是促进创伤后的愈合,通常是缓慢的和
不完整。我们假设,皮肤和肠道等上皮组织的损伤在愈合方面有共同之处,
有一些天生的伤害反应,实际上抑制了愈合。这笔赠款的目标是定义
这种抑制的机制,希望开发治疗方法,以促进愈合。我们将测试是否抑制了
这些抑制愈合的途径可以促进肠道或皮肤受伤或感染后的再生。
希望提出一种新的治疗方法来帮助从不同的损伤中恢复。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Luis Andres Garza其他文献
Luis Andres Garza的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Luis Andres Garza', 18)}}的其他基金
Injection of autologous volar fibroblasts to the stump site to allow pressure adaptation and enhanced prosthetic use in amputees
将自体掌侧成纤维细胞注射到残肢部位,以适应截肢者的压力并增强假肢的使用
- 批准号:
10492492 - 财政年份:2021
- 资助金额:
$ 36.03万 - 项目类别:
Injection of autologous volar fibroblasts to the stump site to allow pressure adaptation and enhanced prosthetic use in amputees
将自体掌侧成纤维细胞注射到残肢部位,以适应截肢者的压力并增强假肢的使用
- 批准号:
10276515 - 财政年份:2021
- 资助金额:
$ 36.03万 - 项目类别:
Retinoic acid synthesis induced by noncoding dsRNA controls Regeneration
非编码 dsRNA 诱导的视黄酸合成控制再生
- 批准号:
10025168 - 财政年份:2019
- 资助金额:
$ 36.03万 - 项目类别:
Retinoic acid synthesis induced by noncoding dsRNA controls Regeneration
非编码 dsRNA 诱导的视黄酸合成控制再生
- 批准号:
10469347 - 财政年份:2019
- 资助金额:
$ 36.03万 - 项目类别:
Retinoic acid synthesis induced by noncoding dsRNA controls Regeneration
非编码 dsRNA 诱导的视黄酸合成控制再生
- 批准号:
10684735 - 财政年份:2019
- 资助金额:
$ 36.03万 - 项目类别:
Towards the clinical testing of dsRNA to promote wound induced hair neogenesis
进行 dsRNA 促进伤口诱导毛发新生的临床测试
- 批准号:
9102384 - 财政年份:2016
- 资助金额:
$ 36.03万 - 项目类别:
Mechanism and clinical pilot tst of volar fibroblast to create ectopic volar skin
掌侧成纤维细胞形成异位掌侧皮肤的机制及临床试验
- 批准号:
9322010 - 财政年份:2013
- 资助金额:
$ 36.03万 - 项目类别:
Mechanism and clinical pilot tst of volar fibroblast to create ectopic volar skin
掌侧成纤维细胞形成异位掌侧皮肤的机制及临床试验
- 批准号:
8713420 - 财政年份:2013
- 资助金额:
$ 36.03万 - 项目类别:
Mechanism and clinical pilot tst of volar fibroblast to create ectopic volar skin
掌侧成纤维细胞形成异位掌侧皮肤的机制及临床试验
- 批准号:
9130108 - 财政年份:2013
- 资助金额:
$ 36.03万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 36.03万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 36.03万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 36.03万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 36.03万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 36.03万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 36.03万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 36.03万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 36.03万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 36.03万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 36.03万 - 项目类别: